Form 6-K Galmed Pharmaceuticals For: Aug 25
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Galmed Pharmaceuticals terminates licensing deal, plans minority stake
August 25, 2025 8:16 AM EDTGalmed Pharmaceuticals Ltd. (NASDAQ: GLMD) terminated a licensing agreement with Entomus s.r.o. for development and commercialization of a Self-Emulsifying Drug Delivery System formulation, according to a company statement.
The pharmaceutical company ended the binding term sheet following additional due diligence and... More
Galmed Pharmaceuticals terminates licensing deal, plans minority stake
August 25, 2025 7:41 AM EDTGalmed Pharmaceuticals Ltd. (NASDAQ: GLMD) terminated a licensing agreement with Entomus s.r.o. for development and commercialization of a Self-Emulsifying Drug Delivery System formulation, according to a company statement.
The pharmaceutical company ended the binding term sheet following additional due diligence and... More
